IDeAl talk at FDA

Coordinator Ralf-Dieter Hilgers and Nicole Heussen give a talk at the U.S. Food and Drug Administration on 2016 May 6 titled “Does Randomization protect against bias? What can be done to improve the level of clinical evidence of effectiveness?”. In their talk, they  share new findings on small population group methodology and connect them with the regulatory guidelines currently in effect. The talk will have a great impact on the awareness of IDeAl research at the regulators office in the U.S., and will therefore also impact the European small population groups.